Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.055 | 0.7 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |